Quick Answer
Seres Therapeutics, Inc. reported Total Assets of $138.19 million for fiscal year 2025.
Seres Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $138.19M | -1.2% |
| 2024 | $139.81M | -61.0% |
| 2023 | $358.60M | +2.8% |
| 2022 | $348.78M | -1.7% |
| 2021 | $354.86M | +3.5% |
| 2020 | $342.94M | +158.9% |
| 2019 | $132.44M | +9.9% |
| 2018 | $120.47M | -36.4% |
| 2017 | $189.52M | -30.5% |
| 2016 | $272.65M | +25.7% |
| 2015 | $216.90M | +84.8% |
| 2014 | $117.34M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $143.47M | -19.7% | -0.2% |
| June 30, 2025 | $143.80M | -55.3% | -12.4% |
| March 31, 2025 | $164.18M | -51.9% | +17.4% |
| December 31, 2024 | $139.81M | -61.0% | -21.8% |
| September 30, 2024 | $178.74M | -51.4% | -44.4% |
| June 30, 2024 | $321.73M | -20.8% | -5.7% |
| March 31, 2024 | $341.26M | +26.3% | -4.8% |
| December 31, 2023 | $358.60M | +2.8% | -2.5% |
- Seres Therapeutics, Inc. showed a decrease of -1.2% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Seres Therapeutics, Inc.’s total assets has grown by 17.8% (from $117.34 million to $138.19 million).
- The most recent figure is from Seres Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: